Month: November 2020

One of the most respected prostate cancer research facilities is the National Cancer Institute: The National Cancer Institute (NCI) is the federal government’s principal agency for cancer research and training. Established under the National Cancer Institute Act of 1937, NCI is part of the National Institutes of Health (NIH), one of 11 agencies that make keep reading

NOTE: The following is an update to a blog I posted in early 2020. Metformin red flag, December 2019 I have occasionally reported on studies that link a possible preventive effect against prostate cancer (PCa) with the common diabetes drug, metformin. In February 2020 I notified readers that the FDA had issued a Dec. 2019 keep reading